24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Gene Tied to Balding May Also Raise COVID Risks for MenTime Spent in ICU Linked to Higher Odds for Suicide LaterState of Mind Matters for Survival After Heart AttackFailing Kidneys Could Bring Higher Dementia RiskAir Pollution Can Harm Kids' Hearts for a LifetimePoll Finds Many Parents Hesitant to Get Younger Kids VaccinatedObesity More Deadly for Men Than Women When COVID StrikesIsrael Study: Pfizer Vaccine Gives 95% Protection Against Illness, Hospitalization & DeathReal-World Studies Show Pfizer Vaccine Shields Against COVID Variants1 in 4 U.S. Teens Has Had a Concussion: StudyWhat's the Right Amount of Sleep for a Healthy Heart?U.S. COVID Outlook Shows Big Improvement by July'Prediabetes' Raises Odds for Heart Attack, StrokeA Vitamin Could Be Key to Women's Pain After Knee ReplacementBiden Sets New Goal of Vaccinating 70% of Americans by July 4Wildfires Are Changing the Seasonal Air Quality of the U.S. WestMany Americans Wrong About Sun's Skin Cancer Dangers: PollNot Just About Antibodies: Why mRNA COVID Vaccines May Shield From VariantsYou Got Your COVID Shot: What to Do With That Vaccine CardFDA Plans to OK Pfizer Vaccine for Those Aged 12 and UpAHA News: As Pre-Pandemic Activities Return, So Does AnxietyCOVID Anxieties Still High for Americans: PollCOVID Vaccination in Pregnancy May Pass Helpful Antibodies to BabyWhy U.S. Hispanics Got COVID at Higher Rates: Their JobsHerd Immunity for Americans May Be an Elusive Goal, Experts SayUrgent Care or the ER? Which Should You Choose?Needle Anxiety Behind J&J COVID Vaccine Reaction Clusters: Study1 in 5 Patients on Kidney Dialysis Say No to COVID-19 Vaccine: StudyYoung, Immune-Compromised Patients Are Hotspots for Coronavirus Mutations: StudyYour Blood Type Might Raise Odds for Certain Health ConditionsCOVID Deaths Continue to Decline in U.S.Researchers Seek Antiviral Pill That Would Ease COVID SeverityAHA News: Take Stock of Your Health With This Post-Lockdown ChecklistPoll Reveals Who's Most Vaccine-Hesitant in America and WhyGood Stroke Recovery May Depend on Your ZIP Code: StudyNew Advice for Blood Pressure That's a Bit Too HighCOVID-19 and Advanced Diabetes Can Be a Deadly Mix: StudyMany U.S. Colleges Will Mandate Vaccines on Campus Next Fall: SurveyPfizer/Moderna Vaccine Protection: 64% at First Dose, 94% at SecondAbout 1 in 7 Who Get Pfizer Vaccine Will Have Any 'Systemic' Side Effect: StudyPolls Find Most U.S. Young People Take COVID Threat SeriouslyAHA News: Experts Remain Confident About Vaccine Safety MonitoringNothing to Sniff at: Depression Common for People With COVID-Linked Smell LossHead Injury, Alzheimer's Appear to Affect Brain in Similar WaysCDC Says Vaccinated Can Shed Masks Outside, Except in CrowdsCOVID-19 Could Raise Odds for Heart Failure, Even in Those With No Prior Heart RiskU.S. to Share Up to 60 Million Doses of AstraZeneca Vaccine With Other CountriesLow Risk of Mom Passing COVID to NewbornThese Factors Could Lead to a Real Pain in the NeckWhy COVID Infection Raises Risks in Pregnancy
Questions and AnswersLinks
Related Topics

Diabetes

Pandemic Has Put Many Clinical Trials on Hold

HealthDay News
by Robert Preidt
Updated: Apr 9th 2021

new article illustration

FRIDAY, April 9, 2021 (HealthDay News) -- Fewer clinical trials are being completed during the pandemic, which experts say could affect medical research for decades to come.

Previously, it was reported that more than 80% of clinical trials were suspended between March 1 and April 26, 2020, with the pandemic cited as the main reason.

In this study, researchers at Penn State College of Medicine examined more than 117,000 trials in the United States, Europe, Asia and other regions to find out how the pandemic has affected clinical research.

"This analysis revealed that the impact was substantial -- particularly for trials funded by government, academic or medical entities," said study author Nour Hawila, a doctoral candidate in biostatistics.

Researchers found that between April and October of last year, study completion rates dropped worldwide between 13% and 23%, depending on trials' sponsors and locations. Patient enrollment in trials was lower in April 2020 than in April 2019.

Trials sponsored by pharmaceutical, biotechnology and therapeutic companies were more likely to complete enrollment, according to findings published recently in the journal Clinical and Translational Science.

"The pandemic has made it more difficult for researchers to recruit and follow up on patients in clinical trials," Hawila said in a Penn State news release.

The study also found that new interventional trial submissions to ClinicalTrials.gov -- a website that contains information on the status of thousands of clinical trials in the United States -- dropped roughly 10% between April and October of last year.

The study also found a shift in research priorities -- 472 (11%) of trials submitted between April and October 2020 were pandemic-related.

The pandemic had less of an impact on clinical trials in some parts of the world, however. For example, Egypt had an increase in both submitted (69%) and completed (73%) clinical trials, likely due to a recent law governing medical research, researchers said.

"Clinical research response to the pandemic has been robust," said co-author Arthur Berg, associate professor of public health sciences. "But the impact of the pandemic on other types of clinical trials will be felt for decades to come."

He added that as shown in Egypt, timely governmental action may be able to reverse the pandemic's impact on research.

More information

The U.S. National Institutes of Health has more on clinical trials.

SOURCE: Penn State University, news release, April 7, 2021